Product Information
LANSOPRAZOLE DR 15 MG CAPSULE is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.4283 per EA under NDC 45802087801. Its NADAC has been published 198 times since Nov 9, 2022.
FDA first approved this application on May 18, 2012.
Strength
15 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802087801
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202319FDA Approved
5/18/2012
On Market Since
7/29/2021
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has been published 198 times since Nov 9, 2022, and over the history we have for it it has declined 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4283 per EA |
|---|---|
| All-time high | $0.4918 (Jul 10, 2024) |
| All-time low | $0.3778 (Oct 18, 2023) |
| 52-week high | $0.4629 |
| 52-week low | $0.4184 |
| Median price | $0.4369 |
| Average price | $0.4378 |
| Largest weekly change | -19.6% (Oct 18, 2023) |
| Weeks tracked | 198 |
| Tracking since | Nov 9, 2022 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 15 MG CAPSULE, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.4283 per EA (NDC 45802087801), effective Aug 19, 2026.
How has the price of LANSOPRAZOLE DR 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has declined 2.1%. It has been tracked across 198 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 15 MG CAPSULE?
Since Nov 9, 2022, the NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has ranged from a low of $0.3778 (Oct 18, 2023) to a high of $0.4918 (Jul 10, 2024), with a median of $0.4369 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 15 MG CAPSULE?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LANSOPRAZOLE DR 15 MG CAPSULE, is $0.1470 per EA — about 66% below LANSOPRAZOLE DR 15 MG CAPSULE.
Who manufactures LANSOPRAZOLE DR 15 MG CAPSULE?
LANSOPRAZOLE DR 15 MG CAPSULE (NDC 45802087801) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.